Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
evx-01 (1 trial)
evx-02 (1 trial)
pembrolizumab (keytruda) (1 trial)
Melanoma (Phase 2)
Trials (2 total)
Trial APIs (3 total)